Comparison · checked November 2026
PortfoliosLab alternatives: MEDGE vs PortfoliosLab
PortfoliosLab is a low-cost toolkit of portfolio analysis, optimizers and screeners, priced by the number of calculations you run each month. MEDGE is built around one portfolio at a time: why each holding helped or hurt, how the mix behaves in bear and bull markets, and what a shock you define does to every position, on US and European listings.
Published by MEDGE Capital. PortfoliosLab details from its public pages, checked in November 2026: PortfoliosLab subscription · PortfoliosLab portfolio analysis. Prices are list prices for one user, before tax; check with the vendor before you buy.
| PortfoliosLab | MEDGE | |
|---|---|---|
| Price | Free; Plus $10 a month ($100 a year), Pro $25 ($250 a year), Max $90 ($900 a year) | Free plan with no time limit; Essential €14.99, Plus €39.99, Pro €59.99, Advisor €159 a month, two months free with yearly billing |
| Free plan | 15 holdings per portfolio, 10 calculations a month, the last 5 years of history | Backtesting lab, Monte Carlo and optimization on 12 objectives, up to 10 holdings per analysis, one saved portfolio |
| How usage is counted | Calculations per month: 100 on Plus, 2,000 on Pro, 10,000 on Max | By plan features and saved portfolios, not by calculations a month |
| Optimization | Mean-variance, risk parity, HRP and HERC; Nested Clusters on Max | 12 objectives, including Max Sharpe, Max Sortino, Min CVaR and Risk Parity, on every plan |
| Why it performed | Returns, risk metrics, drawdowns and correlations of the portfolio | Attribution per holding for any window, bear, neutral and bull regimes, what-if replays that remove or replace a holding |
| Stress scenarios | No custom scenario shocks; historical periods of the backtest | Stress Lab (from Essential): 11 ready scenarios or your own shocks on 45 benchmarks, propagated to every holding |
| Instruments | Stocks, ETFs and mutual funds, with screeners for each | US and European listings, UCITS ETFs included, each analysed in its own trading currency |
| Market data next to the portfolio | 13F portfolios of well-known investors | SEC 13F and Form 4, CFTC positioning (COT), central banks, Treasury yields |
| AI assistants | Public API and MCP server, with a monthly call allowance | MCP server for Claude, ChatGPT and Cursor on every plan, Free included |
PortfoliosLab fits if…
- you run many optimizations or screens and want to pay by volume;
- you need portfolios with hundreds of holdings;
- cluster-based optimizers such as HERC or Nested Clusters are what you are after.
MEDGE fits if…
- you want to know which holding drove a loss and what to change, not only the totals;
- you want to test a specific shock, such as a tech sell-off or a rate jump, on your own holdings;
- you hold a mix of US and European listings and want each one in its own currency, with positioning data alongside.
Frequently asked questions
- What is a good alternative to PortfoliosLab?
- It depends on the job. For volume screening and cluster optimizers, PortfoliosLab’s own paid plans go further. For diagnosing one real portfolio, MEDGE adds per-holding attribution, bear and bull regimes, what-if replays and the Stress Lab, with a free plan that has no time limit. testfolio and Portfolio Visualizer are other options for long-history backtests.
- Is MEDGE cheaper than PortfoliosLab?
- They are priced differently. PortfoliosLab charges by calculations a month: $100 a year for Plus, $250 for Pro, $900 for Max. MEDGE charges by features: free, then €14.99 a month for Essential (€149 a year with yearly billing), which adds the Stress Lab, full risk metrics and reports. Compare the plan that covers what you actually use.
- Does MEDGE work with European ETFs?
- Yes. MEDGE analyses UCITS ETFs and other European listings next to US stocks and ETFs, each on its own price history and in its own trading currency, so a fund’s return is not mixed with a currency move.
Other comparisons
Bring your holdings. See where the risk sits.
Free plan with no time limit, no brokerage connection. Not investment advice.
Start free